Showing results (181-190 of 2,104) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 28, 2005
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstaclesOliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.CNS Drugs|December 9, 2004
Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidenceArthur M Pancioli, Thomas G BrottCNS Drugs|April 9, 2005
Social functioning: should it become an endpoint in trials of antidepressants?Per BechCNS Drugs|April 9, 2005
HIV-associated neuropathic pain: epidemiology, pathophysiology and managementSusama Verma, Lydia Estanislao, David SimpsonCNS Drugs|August 28, 2004
Future antidepressants: what is in the pipeline and what is missing?Fokko J Bosker, Ben H C Westerink, Thomas I F H Cremers, et al.CNS Drugs|June 21, 2005
Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic reviewLouis S Matza, Timothy M Baker, Dennis A RevickiCNS Drugs|June 21, 2005
Spotlight on olanzapine in bipolar I disorderPaul L McCormack, Lynda R WisemanCNS Drugs|January 18, 2005
Intramuscular interferon-beta-1a: in patients at high risk of developing clinically definite multiple sclerosisM Asif A Siddiqui, Keri WellingtonCNS Drugs|August 5, 2004
Sociodemographic profile of insomniac patients across national surveysFrançois-André Allaert, Renaud UrbinelliPageof 211